LYTGOBI 4 mg/1
FUTIBATINIB · TABLET · TAIHO PHARMACEUTICAL CO., LTD.
No Recall History
Plain English
LYTGOBI is a tablet containing futibatinib at 4 mg/1, taken oral. Manufactured by TAIHO PHARMACEUTICAL CO., LTD..
Key Facts
- Brand Name
- LYTGOBI
- Generic Name
- FUTIBATINIB
- NDC Code (Product)
64842-0120- Manufacturer
- TAIHO PHARMACEUTICAL CO., LTD.
- Strength
- 4 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA214801
- Marketing Start
- 02/03/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is LYTGOBI used for?
LYTGOBI contains FUTIBATINIB. It is a tablet taken oral. Consult your doctor for specific uses.
Is LYTGOBI a controlled substance?
LYTGOBI is not classified as a controlled substance by the DEA.
What is the generic name for LYTGOBI?
The generic name for LYTGOBI is FUTIBATINIB. There are no other listed brand versions of FUTIBATINIB.
What is the NDC code for LYTGOBI 4 mg/1?
The NDC (National Drug Code) for LYTGOBI 4 mg/1 is 64842-0120, listed by TAIHO PHARMACEUTICAL CO., LTD..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)